Scholarlink

<p>Primary brain calcification (PBC) is a neurodegenerative disease that causes bilateral ectopic calcification in the brain. In this study, using newly generated <i>Slc20a2</i> knockout (<i>Slc20a2</i><sup>−/−</sup>) mice, we establish an in vivo model for PBC. In contrast to heterozygous <i>Slc20a2</i><sup>+/−</sup> mice (9/9 animals) showing no obvious abnormalities, the homozygous <i>Slc20a2</i><sup><i>−/−</i></sup> mice exhibited severe calcification at 11 months of age (5/5 animals). Whilst smaller in size and number, the deposits were also detectable in 5-month-old <i>Slc20a2</i><sup>−/−</sup> mice (2/2 animals). By contrast, no obvious alterations were detectable in visceral organs, including the lung, kidney, liver, and spleen. Consistently, in PBC patients, despite the systemic mineral metabolic disturbance, calcification occurs only in a brain restricted manner. Hence, these observations suggest that our mouse model is capable of recapitulating certain aspects of human PBC etiology. In summary, our data suggested the utility of an in vivo PBC mouse model in understanding the pathological mechanisms behind brain calcification, which leads in development of novel therapeutics against PBC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Generation of a new Slc20a2 knockout mouse line as in vivo model for primary brain calcification

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月20日

查看全文
  • Hisaka Kurita,
  • Hiroki Kitaura,
  • Kazuya Nishii,
  • Tomohiko Masaka,
  • Kazuki Ohuchi,
  • Masatoshi Inden,
  • Akiyoshi Kakita,
  • Masatake Osawa,
  • Isao Hozumi

摘要

Primary brain calcification (PBC) is a neurodegenerative disease that causes bilateral ectopic calcification in the brain. In this study, using newly generated Slc20a2 knockout (Slc20a2−/−) mice, we establish an in vivo model for PBC. In contrast to heterozygous Slc20a2+/− mice (9/9 animals) showing no obvious abnormalities, the homozygous Slc20a2−/− mice exhibited severe calcification at 11 months of age (5/5 animals). Whilst smaller in size and number, the deposits were also detectable in 5-month-old Slc20a2−/− mice (2/2 animals). By contrast, no obvious alterations were detectable in visceral organs, including the lung, kidney, liver, and spleen. Consistently, in PBC patients, despite the systemic mineral metabolic disturbance, calcification occurs only in a brain restricted manner. Hence, these observations suggest that our mouse model is capable of recapitulating certain aspects of human PBC etiology. In summary, our data suggested the utility of an in vivo PBC mouse model in understanding the pathological mechanisms behind brain calcification, which leads in development of novel therapeutics against PBC.